Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated.
De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB.
De la Garza-Ramos C, et al. Among authors: patel t.
J Hepatocell Carcinoma. 2021 Jul 30;8:861-870. doi: 10.2147/JHC.S319215. eCollection 2021.
J Hepatocell Carcinoma. 2021.
PMID: 34368021
Free PMC article.